Histological and Immunohistochemical Revision of Hepatocellular Adenomas: A Learning Experience
Open Access
- 28 February 2013
- journal article
- research article
- Published by Wiley in International Journal of Hepatology
- Vol. 2013, 1-8
Abstract
Light has been shed on the genotype/phenotype correlation in hepatocellular adenoma (HCA) recognizingHNF1α-inactivated HCA (H-HCA), inflammatory HCA (IHCA), andβ-catenin-activated HCA (b-HCA). We reviewed retrospectively our surgical HCA series to learn how to recognize the different subtypes histopathologically and how to interpret adequately their immunohistochemical staining. From January 1992 to January 2012, 37 patients underwent surgical resection for HCA in our institution. Nine had H-HCA (25%) characterized by steatosis and loss of L-FABP expression; 20 had IHCA (55.5%) showing CRP and/or SAA expression, sinusoidal dilatation, and variable inflammation; and 1 patient had both H-HCA and IHCA. In 5 patients (14%), b-HCA with GS andβ-catenin nuclear positivity was diagnosed, two already with hepatocellular carcinoma. Two cases (5.5%) remained unclassified. One of the b-HCA showed also the H-HCA histological and immunohistochemical characteristics suggesting a subgroup ofβ-catenin-activated/HNF1α-inactivated HCA, another b-HCA exhibited the IHCA histological and immunohistochemical characteristics suggesting a subgroup ofβ-catenin-activated/inflammatory HCA. Interestingly, three patients had underlying vascular abnormalities. Using the recently published criteria enabled us to classify histopathologically our retrospective HCA surgical series with accurate recognition of b-HCA for which we confirm the higher risk of malignant transformation. We also underlined the association between HCA and vascular abnormalities.Keywords
This publication has 31 references indexed in Scilit:
- Hepatocellular adenoma in glycogen storage disorder type I: a clinicopathological and molecular studyHistopathology, 2012
- Can a decision‐making model be justified in the management of hepatocellular adenoma?Liver International, 2011
- Hepatocellular adenomas: Accuracy of magnetic resonance imaging and liver biopsy in subtype classificationHepatology, 2011
- Hepatocellular adenoma management and phenotypic classificationHepatology, 2009
- Frequent in-frame somatic deletions activate gp130 in inflammatory hepatocellular tumoursNature, 2008
- Insight into congenital absence of the portal vein: Is it rare?World Journal of Gastroenterology, 2008
- Hepatobiliary and pancreatic: Hepatic adenoma, focal nodular hyperplasia and congenital absence of the portal veinJournal of Gastroenterology and Hepatology, 2006
- Hepatic adenomas: Presumed innocent until proven to be beta-catenin mutatedHepatology, 2006
- p53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasiaHepatology, 2002
- Liver pathology associated with the use of anabolic‐androgenic steroidsLiver International, 1992